Ankara Üniversitesi Tıp Fakültesi Mecmuası

0365-8104 1307-5608

Ankara University

Nefroloji

Investigation of Lipoproteins in Kidney Diseases

Böbrek Hastalıklarında Lipoproteinlerin Araştırılması

Tokgöz

Güner

ANKARA UNIVERSITY, ANKARA FACULTY OF MEDICINE

09 30 1978

31 3 612 620 07 01 1978 09 30 1978

1947

Ankara Üniversitesi Tıp Fakültesi Mecmuası

23 akut glomerulonefrit, 40 kronik glomerulonefrit, 6 akut hecmelerle seyreden kronik glomerulonefrit, 42 nefrotik sendromlu vakada serum protein seviyesinin idrar lipoprotein değişikliklerini ne derecede etkilediğini araştırdık. İdrarda alfa lipoprotein tesbit edilen ve idrarda alfa lipoprotein tesbit edlemeyen grublarda serum albumin, serum globulin, serum protein elektroforezi, idrarla itrah edilen protein değerleri ortalama arası farkının istatistiki önemi araştırıldı. Bu araştırmada tesbit edilen en yüksek değeri kronik glomerulonefritli vakalarda idrarla itrah edilen proteinin ortalamalar arası farkı (& — | ,941) olmasına rağmen İstatistiki olarak ifade etmemektedir. Her 4 grubda bu değerler arasında istatistiki olarak önemli bir fark bulunamamıştır. (p7>0,05). Bu çalışmada böbrek hastalıklarında idrar lipoprotein seviyesi arasında bir ilişki bulunamamıştır.

We investigated to what extent serum protein level affects urine lipoprotein changes in 23 acute glomerulonephritis, 40 chronic glomerulonephritis, 6 chronic glomerulonephritis with acute episodes, and 42 nephrotic syndrome cases. The statistical significance of the difference between the mean values of serum albumin, serum globulin, serum protein electrophoresis, and urine excreted protein in the groups where alpha lipoprotein was detected in urine and where alpha lipoprotein was not detected in urine was investigated. Although the highest value determined in this study was the difference between the mean values of urine excreted protein in chronic glomerulonephritis cases (& — | .941), it is not statistically significant. No statistically significant difference was found between these values in all 4 groups. (p7>0.05). iIn this study, no relationship was found between urine lipoprotein levels in kidney diseases.

böbrek protein lipid

1. Nelson, G.I. : Blood lipid and lipoproteins guantitation Composition and metabolism, 473-691, 1972. i

2. Newmark, SR, Anderson, C.F., Donadid, IV, and Ellefson, R.D. : Lipoprotein profiles in adult nephrotics. Mayo Clin. Pro, 50 : 359, 1975. '

3. Baxter, J.H., Goodman, H.C., and Havel, R.J. : Serum lipid and lipoproteins alterations in nephrosis, 1. Clin. İnvest. 39 : 455, 1960. i 4. Baxter, J.H. Hyperlipoproteinemia in nephrosis. Arch. İnt. Med. 109 : 742, 1962.

5. Shanley, B.C., and Seedat, Y.K. Serum lipoprotein patterns in Bantu and İndian patients with nephrotic syndrom. $. Afr. Med. J. 47 ; 187-190, 552, 1973.

6. Chatys Gorska, L. Blood lipids and lipoproteins in children with nephrotic Syndrom. Pediatr. Pol, 48 : 713-720, 1973. ni

7. Chopra, J.S. And Mallick, N.P. : Hyperlipoproteinemias in nephrotic syndrom. Lancet. 11:317, 1971.

8. Brons, M., Christensen, N.C. and Horder, M. : Hyperlipoproteinemia in patients with chronic renal failure. Acta Med. Scan. 192 : 119-123, 1972. i

9. Baxter, J.H., Goodman, H.C., And Allen, J.C. : Effecis of infusions of serim lipids and lipoproteins in neprosis. J. Clin İnves. 40 : 490, 1961.

10. Heyman, V.V., Nash, G., Gilkey, C., and Lewis, M. : Studies on the causal:role of hypoalhuminemia in experimental nephrotic hyperlipemia. J. Clin. İnves. 37 : 808, 1958.

11. Klahr, S., Tripathy, K., and Bolanos, O. : gualitative and guantitative analysis of urinary lipids in the nephrotic syndrom. 3. Clin. İnvest, 46 : 1475, 1967.

12. Hyman, L.R., Wong, P.V.V.K., Grossman, A. : Plasma lipoprotein lipase in children with idiopathic nephrotic syndrom. Pediatrcs, 44 : 1021- 1024, 1969,

13. Rosenman, H.R., Byers, S., and Friedman, M. : Plasma lipid interrationships in experimental nephrosis. Clin. Chem. Acta, 30 : 787-794, 1970.

14. Bagdade, JI.D., Porte, D. and Bierman, E.L. : Hypertrigiyceridemia. A metabolic' conseguence of chronic renal failure. New. Eng. 1. Med. 279 : 181, 1968,

15. Bagdade, J.D. : Jremic lipemia : Unrecognized abnormality in trigliseride productionand removal, Arch. İnt, Med. 126; 875, 1970.

16. Neuman, M., West, M., and Zimmerman, HJ. : The relationship, beetwen proteinüria and fatty elemenfs in the urine sedimet. Amer. J. Med. Scan. 101 : 677, 1961.

17. Radding, C.M. and Steinberg, D. : Studies on the synthesis and secretion of serum lipoproteins by rat Hver slices. 1. Clin. İnves, 39 ; 455, 1960.

18. Wils, M.R. : The biochemical conseguences of chronic renal failure s : 129-131, 1971.

19. Luzio, N.R. and Houck, C.R. : The role of the kidney in the süology of renal hıyperlipemia J. Clin. İnves. 35: 1381, 1956.

20. Rosenman, R.H., and Byers, S. O. : Study of possible role of lipoprotein lipase deficiency in nephrosic hyperlipemia. J. Clin. İnves. 38 : 1036, 1959,

21. Jensen, H. : Plasma protein and lipid pattern in nephrotic syndrom, Acta Med. Scan.182 : 4, 465, 1967,

22. Me Kenzie, I. F.C., and Nestel, P.J. : Studies on the turnover of trigliseride and esterfied cholesterol in subjecis with the nephrotic syndrome, J. Clin. İnves. 47, 1685, 1968.

23. Heymann, W., and Hackel, D.B. : Role of liver in pathogenesis of experimental nephrotic hyperlipemia, Metabolism, 4 : 258, 1955.

24. Marsh, J.B. and Drabkin, D.L. : Experimental reconsiruction of metabolic pattern of lipid nephrosis : Key role of hepotic protein synthesis in hyperlipemia. Metabolism, 9 : 946-955, 1960.

25. Bagdade, J.D. : Disorders of carbonhydrate and lipid metabolism in üremia, Nephron 4: 153-162, 1975.